Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Cardiovasc Pathol. 2013 Jul-Aug;22(4):287-93. doi: 10.1016/j.carpath.2012.12.002. Epub 2013 Jan 10.
Centrilobular ground-glass opacity (GGO) is one of the characteristic findings in chest high-resolution computed tomography (HRCT) of patients with pulmonary veno-occlusive disease (PVOD) and patients with pulmonary capillary hemangiomatosis (PCH). However, clinical differential diagnosis of these two diseases is difficult and has not been established. In order to clarify their differences, we compared the sizes of GGOs in chest HRCT and the sizes of capillary assemblies in pulmonary vascular casts between patients diagnosed pathologically with PVOD and PCH.
We evaluated chest HRCT images for four patients with idiopathic pulmonary arterial hypertension (IPAH), three patients with PVOD and three patients with PCH, and we evaluated pulmonary vascular casts of lung tissues obtained from those patients at lung transplantation or autopsy.
Centrilobular GGOs in chest HRCT were observed in patients with PVOD and patients with PCH but not in patients with IPAH. We measured the longest diameter of the GGOs. The size of centrilobular GGOs was significantly larger in patients with PCH than in patients with PVOD (5.60±1.43 mm versus 2.51±0.79 mm, P<.01). We succeeded in visualization of the 3-dimensional structures of pulmonary capillary vessels obtained from the same patients with PVOD and PCH undergoing lung transplantation or autopsy and measured the diameters of capillary assemblies. The longest diameter of capillary assemblies was also significantly larger in patients with PCH than in patients with PVOD (5.44±1.71 mm versus 3.07±1.07 mm, P<.01).
Measurement of the sizes of centrilobular GGOs in HRCT is a simple and useful method for clinical differential diagnosis of PVOD and PCH.
在肺静脉闭塞病(PVOD)和肺毛细血管血管瘤病(PCH)患者的胸部高分辨率 CT(HRCT)中,局灶性磨玻璃样混浊(GGO)是特征性发现之一。然而,这两种疾病的临床鉴别诊断很困难,尚未建立。为了阐明它们的差异,我们比较了经病理诊断为 PVOD 和 PCH 的患者的胸部 HRCT 中的 GGO 大小和肺血管铸型中的毛细血管集合体的大小。
我们评估了 4 例特发性肺动脉高压(IPAH)患者、3 例 PVOD 患者和 3 例 PCH 患者的胸部 HRCT 图像,并评估了这些患者在肺移植或尸检时获得的肺组织的肺血管铸型。
PVOD 患者和 PCH 患者的胸部 HRCT 中可见局灶性磨玻璃样混浊,但 IPAH 患者未见。我们测量了 GGO 的最长直径。PCH 患者的局灶性磨玻璃样混浊的大小明显大于 PVOD 患者(5.60±1.43mm 比 2.51±0.79mm,P<.01)。我们成功地可视化了来自接受肺移植或尸检的相同 PVOD 和 PCH 患者的肺毛细血管血管的 3 维结构,并测量了毛细血管集合体的直径。PCH 患者的毛细血管集合体的最长直径也明显大于 PVOD 患者(5.44±1.71mm 比 3.07±1.07mm,P<.01)。
HRCT 中局灶性磨玻璃样混浊大小的测量是 PVOD 和 PCH 临床鉴别诊断的一种简单而有用的方法。